Ziqi Wang
Zhengzhou University
16 Papers
10 Citations
Ziqi Wang is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy.
Haixia Li,Chenyu Wang,Ziqi Wang,Yabo Hu,Guowei Zhang,M. Zhang,Xuanxuan Zheng,Xiaojuan Zhang,Jinbo Yang,Zhiyong Ma,Huijuan Wang +10 more
TL;DR: Compared with chemotherapy, use of the 1st generation of EGFR-TKIs as first-line therapy can improve the short-term efficacy of patients with EGFR uncommon mutations advanced lung adenocarcinoma, but platinum-based chemotherapy showed a longer overall survival.
27
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
Han-Hui Ma,Yingying Guo,Haoneng Tang,Chien Te K. Tseng,Lei Wang,Huifang Zong,Zhenyu Wang,Yang He,Yunsong Chang,Shusheng Wang,Haiqiu Huang,Yong Ke,Min‐Shung Wu,Yuanyuan Zhang,Aleksandra Drelich,Kempaiah Rayavara Kempaiah,Bi Hung Peng,Ailin Wang,KaiYong Yang,H. Yin,Junjun Liu,Yali Yue,Wenbo Xu,Shuangli Zhu,Tianjiao Ji,Xiaoju Zhang,Ziqi Wang,Gang Li,Guang-Mei Liu,Jingjing Song,Li Mu,ZongShang Xiang,Z L Song,Hua Li Chen,Yanlin Bian,Baohong Zhang,Hui Chen,Jia-Wen Zhang,Yu-Jou Liao,Li Zhang,Liu Yang,Yi Chen,J. Gilly,Xiaodong Xiao,Lei Han,Hua Jiang,Yu Xie,Qiang Zhou,Jian-Ming Zhu +48 more
TL;DR: In this article , a monoclonal antibody, 2G1, was developed to neutralize all current SARS-CoV-2 variants and has surprising tolerance to mutations adjacent to or within its interaction epitope.
Efficient Neutralization of SARS-CoV-2 Omicron and Other VOCs by a Broad Spectrum Antibody 8G3
Han-Hui Ma,Chien Te K. Tseng,Huifang Zong,Yu-Jou Liao,Yong Ke,Haoneng Tang,Lei Wang,Zhenyu Wang,Yang He,Yunsong Chang,Shusheng Wang,Aleksandra Drelich,Jason Hsu,Vivian Tat,Min‐Shung Wu,Junjun Liu,Yali Yue,Wenbo Xu,Xiaoju Zhang,Ziqi Wang,Liu Yang,Hua Li Chen,Yanlin Bian,Baohong Zhang,H. Yin,Yi Chen,Enying Zhang,Xiaoxiao Zhang,J. Gilly,Tao Sun,Lei Han,Yu Xie,Hua Jiang,Jian-Ming Zhu +33 more
TL;DR: The results suggest that neutralizing antibodies with breadth remains broad neutralizing activity in tackling SARS-CoV-2 infection despite the universal evasion from EUA antibodies by Omicron variant.
7
Clinical and Prognosic Anylasis of 30 Cases with Double Primary Lung Cancer
TL;DR: Earlier diagnosis, active therapeutic approaches and a strict smoking cessation strategy may improve the prognosis of MPLC.
5
Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma.
Li Yang,Xinxin Fan,Chao Zhou,Ziqi Wang,Zelong Cui,Xuan Wu,Zhiwei Xu,Jia Yang,Xiaoju Zhang +8 more
TL;DR: A ferroptosis-related prognostic signature for LUAD is constructed and functional analysis based on the signature shows potential clinical and functional importance in LUAD patients, and further research on ferroPTosis as a therapeutic target inLUAD is warranted.
5